Jeena Sikho Lifecare (NSE:JSLL) 5-Year EBITDA Growth Rate: 86.30% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
92 GF Score
Price ₹567.65
GF Value ₹779.21
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare 5-Year EBITDA Growth Rate?

Jeena Sikho Lifecare NSE:JSLL -2.21% 92 5-Year EBITDA Growth Rate is 86.30% as of Mar. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 92/100 and a GF Value™ of ₹779.21 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Jeena Sikho Lifecare's EBITDA per Share for the three months ended in Mar. 2026 was ₹6.52.

During the past 12 months, Jeena Sikho Lifecare's average EBITDA Per Share Growth Rate was 142.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 94.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 86.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jeena Sikho Lifecare was 96.10% per year. The lowest was 22.40% per year. And the median was 77.40% per year.

Jeena Sikho Lifecare  (NSE:JSLL) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Jeena Sikho Lifecare 5-Year EBITDA Growth Rate Related Terms

NSE:JSLL vs HCA, THC, DVA: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jeena Sikho Lifecare 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate falls into.


NSE:JSLL
92GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 86.30% mean?
Jeena Sikho Lifecare (NSE:JSLL) has a 5-Year EBITDA Growth Rate of 86.30% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate too high?
Jeena Sikho Lifecare's current 5-Year EBITDA Growth Rate is 86.30%. Overall, Jeena Sikho Lifecare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate compare to HCA and THC?
Jeena Sikho Lifecare's 5-Year EBITDA Growth Rate of 86.30% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current 5-Year EBITDA Growth Rate is 86.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹779.21, compared to a current price of ₹567.65 — trading 27.2% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 86.30%. Jeena Sikho Lifecare's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current 5-Year EBITDA Growth Rate is 86.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹567.65 is trading 27.2% below its estimated GF Value™ of ₹779.21. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • 5-Year EBITDA Growth Rate: 86.30%
  • GF Value™: ₹779.21 vs. price of ₹567.65 (27.2% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
92GF Score

Get the complete analysis for NSE:JSLL

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹567.65
Price
₹779.21
GF Value